Bayer: Evolving Radiology Image Acquisition
Welcome to SBI-ACR 2022.
Bayer has been committed to Radiology for more than 80 years and continues to partner with Radiologists to help guide diagnostic imaging led by our purpose that everyone deserves clear answers about their health.
We are backed by a global footprint and a passionate team across more than 140 countries. Bayer is dedicated to being a leader in the field of medical imaging to shape the patient experience and help patient outcomes. Medical imaging goes beyond scans and images by providing clear answers – it often marks the starting point and guides the subsequent direction for a patient’s journey.
As a life-science company with a heritage of approximately 80 years in Radiology, we can build on our leadership in contrast media and devices. With its comprehensive product portfolio that improves automation, along with unparalleled support and service that maximizes uptime, Bayer is a leader in meeting the needs of Radiology programs and professionals. Bayer products for the Magnetic Resonance (MR) and Computed Tomography (CT), Positron Emission Tomography (PET) and intervention suites in particular, help radiology professionals achieve high-quality diagnostic images to support patient centered care. In addition, Bayer offers
an end-to-end support system, ranging from contrast agents and power injections systems and their sterile disposables to equipment service and enterprise informatics.
Our offerings are targeted to support our customers across the radiology workflow –from contrast agents and devices to digital and artificial intelligence-powered solutions – making us an established partner for radiologists and other physicians as they work to provide the best care for patients.
Building upon its long history in innovation, Bayer is focused on the next generation of advancements, including AI platforms that provide access to a curated marketplace through which healthcare professionals can centrally access digital clinical imaging and workflow applications including AI enabled solutions. The applications will support the complex decision-making process of radiologists and their teams with the goal of earlier disease management and interventions for patients.
Bayer is fully committed to driving innovation in medical imaging and to help answer critical questions in the diagnosis and monitoring of severe diseases, because.... everyone deserves clear answers about their health.